HK-001(Everfront Biotech)

N/A

Report date: 2024/11/21 13:51:10
NME

Base Information

Drug NameHK-001(Everfront Biotech)
Drug Alias NameHK-001(Everfront Biotech)HK001(Everfront Biotech)EF-API-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEverfront Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverfront Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A